• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌患者中除癌症本身外导致死亡的原因:一项基于大规模人群的分析。

What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis.

作者信息

Zheng Xueer, Zhang Anlai, Xiao Yao, Guo Kaibo, Sun Leitao, Ruan Shanming, Fang Fang

机构信息

The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, P. R. China.

Department of medical oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, P. R. China.

出版信息

J Cancer. 2022 Oct 17;13(13):3485-3494. doi: 10.7150/jca.78004. eCollection 2022.

DOI:10.7150/jca.78004
PMID:36313035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9608205/
Abstract

Researches on noncancer causes of death in patients with esophageal cancer (EC) are not in-depth. The objective of this paper is to broadly and deeply explore the causes of death in patients with EC, especially noncancer causes. Information about the demographics, tumor-related characteristics, and causes of death of patients with EC who met the inclusion criteria were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Calculated standardized mortality ratio (SMR) for all causes of death at different follow-up times and performed subgroup analyses. In total, 63,560 patients with EC were retrieved from the public database. And 52,503 died during the follow-up period. Most deaths were due to EC itself within 5 years after diagnosis, but over 10 years, 59% EC patients died from noncancer causes. Cardiovascular disease was the major noncancer cause of death in patients with EC, accounting for 43%. Suicide and self-injury (2%) of EC patients should not be ignored. During the 1-year follow-up period, patients with EC had statistically highest risk of death from septicemia (SMR: 7.61; 95% CI: 6.38-9.00). Within more than 10 years after EC diagnosis, more and more patients died from chronic obstructive pulmonary disease (SMR: 2.38; 95% CI: 1.79-3.10). Although most patients with EC still died from the cancer itself, the role of noncancer causes of death should not be underestimated. These prompt clinicians to pay more attention to the risk of death caused by these noncancer causes, which can provide relevant measures in advance to intervene.

摘要

对食管癌(EC)患者非癌症死因的研究并不深入。本文的目的是广泛而深入地探究EC患者的死因,尤其是非癌症死因。从监测、流行病学和最终结果(SEER)数据库中提取符合纳入标准的EC患者的人口统计学信息、肿瘤相关特征及死因。计算不同随访时间所有死因的标准化死亡比(SMR)并进行亚组分析。共从公共数据库中检索到63560例EC患者。随访期间有52503例死亡。大多数死亡发生在诊断后5年内,原因是EC本身,但超过10年后,59%的EC患者死于非癌症原因。心血管疾病是EC患者非癌症死亡的主要原因,占43%。EC患者的自杀和自残(2%)也不容忽视。在1年随访期内,EC患者因败血症死亡的风险在统计学上最高(SMR:7.61;95%CI:6.38 - 9.00)。在EC诊断后超过10年,越来越多的患者死于慢性阻塞性肺疾病(SMR:2.38;95%CI:1.79 - 3.10)。虽然大多数EC患者仍死于癌症本身,但非癌症死因的作用不应被低估。这些提示临床医生要更加关注这些非癌症死因导致的死亡风险,从而能够提前采取相关措施进行干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0969/9608205/9c8a7121d23b/jcav13p3485g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0969/9608205/413c3698c020/jcav13p3485g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0969/9608205/9c8a7121d23b/jcav13p3485g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0969/9608205/413c3698c020/jcav13p3485g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0969/9608205/9c8a7121d23b/jcav13p3485g002.jpg

相似文献

1
What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis.食管癌患者中除癌症本身外导致死亡的原因:一项基于大规模人群的分析。
J Cancer. 2022 Oct 17;13(13):3485-3494. doi: 10.7150/jca.78004. eCollection 2022.
2
Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study.前列腺癌诊断后的死因:一项基于人群的研究。
Oxid Med Cell Longev. 2022 Apr 23;2022:8145173. doi: 10.1155/2022/8145173. eCollection 2022.
3
Cause of Death During Renal Cell Carcinoma Survivorship: A Contemporary, Population-Based Analysis.肾细胞癌幸存者的死亡原因:一项基于当代人群的分析。
Front Oncol. 2022 Jun 2;12:864132. doi: 10.3389/fonc.2022.864132. eCollection 2022.
4
Cardiovascular disease related death among patients with esophagus cancer: A population-based competing risk analysis.食管癌患者中心血管疾病相关死亡:一项基于人群的竞争风险分析。
Front Oncol. 2022 Sep 15;12:976711. doi: 10.3389/fonc.2022.976711. eCollection 2022.
5
Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result-based analysis.子宫内膜癌幸存者的死因:基于监测、流行病学和最终结果的分析。
Cancer Med. 2023 May;12(9):10917-10930. doi: 10.1002/cam4.5804. Epub 2023 Mar 16.
6
Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study.结直肠癌诊断后的死亡原因:一项基于人群的研究。
Front Oncol. 2021 Mar 30;11:647179. doi: 10.3389/fonc.2021.647179. eCollection 2021.
7
Causes of death after breast cancer diagnosis: A US population-based analysis.乳腺癌诊断后的死因分析:一项基于美国人群的分析。
Cancer. 2020 Apr 1;126(7):1559-1567. doi: 10.1002/cncr.32648. Epub 2019 Dec 16.
8
Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis.前列腺癌幸存者的死因:一项基于美国当代人群的分析。
Cancer. 2021 Aug 15;127(16):2895-2904. doi: 10.1002/cncr.33584. Epub 2021 Apr 21.
9
Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016.2000 年至 2016 年美国转移性前列腺癌患者的死因。
JAMA Netw Open. 2021 Aug 2;4(8):e2119568. doi: 10.1001/jamanetworkopen.2021.19568.
10
Noncancer causes of death in survivors of testicular cancer.睾丸癌幸存者的非癌症死因。
J Natl Cancer Inst. 2007 Apr 4;99(7):533-44. doi: 10.1093/jnci/djk111.

引用本文的文献

1
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer.共病类别对胃肠道癌患者生存的影响。
BMC Cancer. 2025 Feb 8;25(1):225. doi: 10.1186/s12885-025-13517-1.
2
Cardiovascular Disease and Other Competing Causes of Death in Older Kidney Cancer Patients.老年肾癌患者的心血管疾病及其他竞争性死亡原因
Rev Cardiovasc Med. 2025 Jan 14;26(1):25277. doi: 10.31083/RCM25277. eCollection 2025 Jan.
3
Cone Beam Computed Tomography-Based Online Adaptive Radiation Therapy of Esophageal Cancer: First Clinical Experience and Dosimetric Benefits.

本文引用的文献

1
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
2
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019.全球、区域和国家癌症发病率和死亡率 29 种癌症组,2019 年和全球癌症负担趋势分析,1990-2019 年。
J Hematol Oncol. 2021 Nov 22;14(1):197. doi: 10.1186/s13045-021-01213-z.
3
Risk factors associated with suicide among esophageal carcinoma patients from 1975 to 2016.
基于锥形束计算机断层扫描的食管癌在线自适应放射治疗:首例临床经验及剂量学优势
Adv Radiat Oncol. 2024 Oct 22;10(1):101656. doi: 10.1016/j.adro.2024.101656. eCollection 2025 Jan.
4
Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China.中国癌症专科医院重症监护病房癌症患者的特征和结局。
J Cancer Res Clin Oncol. 2024 Apr 20;150(4):205. doi: 10.1007/s00432-024-05727-0.
5
Cause of death among gastric cancer survivors in the United States from 2000 to 2020.美国 2000 年至 2020 年胃癌幸存者的死亡原因。
Medicine (Baltimore). 2024 Feb 23;103(8):e37219. doi: 10.1097/MD.0000000000037219.
6
Causes of death and nomogram for patients with oncologic hepato-biliary-pancreatic disorders: A large-cohort study.肿瘤肝胆胰疾病患者的死亡原因和列线图:一项大样本研究。
Medicine (Baltimore). 2024 Feb 23;103(8):e37187. doi: 10.1097/MD.0000000000037187.
1975 年至 2016 年食管癌患者自杀相关危险因素分析。
Sci Rep. 2021 Sep 21;11(1):18766. doi: 10.1038/s41598-021-98260-w.
4
Current status and application of proton therapy for esophageal cancer.质子治疗食管癌的现状与应用。
Radiother Oncol. 2021 Nov;164:27-36. doi: 10.1016/j.radonc.2021.09.004. Epub 2021 Sep 14.
5
New Trends in Esophageal Cancer Management.食管癌治疗的新趋势
Cancers (Basel). 2021 Jun 17;13(12):3030. doi: 10.3390/cancers13123030.
6
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌(CheckMate 649):一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
7
Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.免疫检查点抑制剂相关心肌炎:表现与机制。
J Clin Invest. 2021 Mar 1;131(5). doi: 10.1172/JCI145186.
8
The Landmark Series: Multimodal Therapy for Esophageal Cancer.里程碑系列:食管癌的多模态治疗。
Ann Surg Oncol. 2021 Jun;28(6):3375-3382. doi: 10.1245/s10434-020-09565-5. Epub 2021 Feb 24.
9
Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015.食管癌:中国 2005 年至 2015 年发病率和死亡率趋势。
Cancer Med. 2021 Mar;10(5):1839-1847. doi: 10.1002/cam4.3647. Epub 2021 Feb 16.
10
Trends in conditional overall survival of esophageal cancer: a population-based study.食管癌条件总生存率的趋势:一项基于人群的研究。
Ann Transl Med. 2021 Jan;9(2):102. doi: 10.21037/atm-20-2798.